Published in Otol Neurotol on October 01, 2012
Contemporary hearing rehabilitation options in patients with aural atresia. Biomed Res Int (2014) 0.82
Grading system for the selection of patients with congenital aural atresia for active middle ear implants. Neuroradiology (2013) 0.79
Vibrant Soundbridge(®) in preschool children with unilateral aural atresia: acceptance and benefit. Eur Arch Otorhinolaryngol (2016) 0.78
A tutorial on implantable hearing amplification options for adults with unilateral microtia and atresia. Biomed Res Int (2014) 0.75
Hearing rehabilitation with single-stage bilateral vibroplasty in a child with Franceschetti syndrome. Eur Arch Otorhinolaryngol (2014) 0.75
Identification and functional analysis of tumor-infiltrating plasmacytoid dendritic cells in head and neck cancer. Cancer Res (2003) 1.44
Cytokines in head and neck cancer. Cytokine Growth Factor Rev (2006) 1.24
B cells immortalized by a mini-Epstein-Barr virus encoding a foreign antigen efficiently reactivate specific cytotoxic T cells. Blood (2002) 1.08
Tumor-specific glycosylation of the carcinoma-associated epithelial cell adhesion molecule EpCAM in head and neck carcinomas. Cancer Lett (2003) 1.06
Glandular tissue from human pancreas and salivary gland yields similar stem cell populations. Eur J Cell Biol (2009) 1.06
Isolation and characterization of adult stem cells from human salivary glands. Stem Cells Dev (2008) 1.05
A case of central sleep apnea strictly dependent upon REM-sleep. J Neurol (2010) 1.02
Role of cytokines in head and neck squamous cell carcinoma. Expert Rev Anticancer Ther (2006) 1.01
Application of the Vibrant Soundbridge to unilateral osseous atresia cases. Laryngoscope (2009) 1.01
Analysis of plasmacytoid and myeloid dendritic cells in nasal epithelium. Clin Vaccine Immunol (2006) 0.97
Innate signaling in otitis media: pathogenesis and recovery. Curr Allergy Asthma Rep (2011) 0.96
The role of DNA sensing and innate immune receptor TLR9 in otitis media. Innate Immun (2011) 0.94
Stem cells in squamous head and neck cancer. Crit Rev Oncol Hematol (2011) 0.94
Permanent up-regulation of regulatory T-lymphocytes in patients with head and neck cancer. Int J Mol Med (2010) 0.93
Potential stem cell marker CD44 is constitutively expressed in permanent cell lines of head and neck cancer. In Vivo (2008) 0.93
Application of the Vibrant Soundbridge in bilateral congenital atresia in toddlers. Acta Otolaryngol (2010) 0.91
Tumour-derived prostaglandin E and transforming growth factor-beta synergize to inhibit plasmacytoid dendritic cell-derived interferon-alpha. Immunology (2009) 0.90
Decreased levels of circulating regulatory NK cells in patients with head and neck cancer throughout all tumor stages. Anticancer Res (2009) 0.89
Impaired monocyte function in cancer patients: restoration with a cyclooxygenase-2 inhibitor. FASEB J (2002) 0.89
The Oral Serine Protease Inhibitor WX-671 - First Experience in Patients with Advanced Head and Neck Carcinoma. Breast Care (Basel) (2008) 0.87
Increased cytokine secretion in head and neck cancer upon p38 mitogen-activated protein kinase activation. Int J Mol Med (2007) 0.86
Inflammatory pseudotumor of the hypopharynx: clinical diagnosis, immunohistochemical findings and treatment of this rare disease. In Vivo (2009) 0.86
Metastases of squamous cell carcinoma of the head and neck show increased levels of nucleotide excision repair protein XPF in vivo that correlate with increased chemoresistance ex vivo. Int J Oncol (2010) 0.84
Cytokine changes in response to radio-/chemotherapeutic treatment in head and neck cancer. Anticancer Res (2013) 0.84
Sleep apnoea in patients after treatment of head neck cancer. Acta Otolaryngol (2009) 0.84
Induction of c-Myc-dependent cell proliferation through toll-like receptor 3 in head and neck cancer. Int J Mol Med (2008) 0.84
Secretion of tumor-promoting and immune suppressive cytokines by cell lines of head and neck squamous cell carcinoma. In Vivo (2006) 0.83
Activated B cells mediate efficient expansion of rare antigen-specific T cells. Hum Immunol (2007) 0.83
Established and novel NF-κB inhibitors lead to downregulation of TLR3 and the proliferation and cytokine secretion in HNSCC. Oral Oncol (2011) 0.83
Functional characterization of novel mutations affecting survivin (BIRC5)-mediated therapy resistance in head and neck cancer patients. Hum Mutat (2012) 0.83
Head and neck cancer triggers increased IL-6 production of CD34+ stem cells from human cord blood. In Vivo (2007) 0.82
LPS-induced mucin expression in human sinus mucosa can be attenuated by hCLCA inhibitors. J Endotoxin Res (2007) 0.82
mTOR inhibitors show promising in vitro activity in bladder cancer and head and neck squamous cell carcinoma. Oncol Rep (2011) 0.82
Phosphorylation of STAT3 in head and neck cancer requires p38 MAPKinase, whereas phosphorylation of STAT1 occurs via a different signaling pathway. Anticancer Res (2011) 0.81
Cartilage tissue engineering using resorbable scaffolds. J Tissue Eng Regen Med (2008) 0.81
Toll-like receptor modulation in head and neck cancer. Crit Rev Immunol (2008) 0.80
Functional alteration of myeloid dendritic cells through head and neck cancer. Anticancer Res (2007) 0.80
Grading system for the selection of patients with congenital aural atresia for active middle ear implants. Neuroradiology (2013) 0.79
Psychometric validation of the youth quality of life-facial differences questionnaire in patients following ear reconstruction with rib cartilage in microtia. Plast Reconstr Surg (2012) 0.79
Biodistribution and radioimmunotherapy of SCCHN in xenotransplantated SCID mice with a 131I-labelled anti-EpCAM monoclonal antibody. Anticancer Res (2007) 0.79
Effect of dexamethasone and ACC on bacteria-induced mucin expression in human airway mucosa. Am J Respir Cell Mol Biol (2007) 0.79
Increased phosphorylation of STAT5b, but not STAT5a, in nasal polyps. Am J Rhinol Allergy (2015) 0.79
Isolation of human myeloid dendritic cells from tumor tissue and peripheral blood. In Vivo (2006) 0.79
Dexamethasone and N-acetyl-cysteine attenuate Pseudomonas aeruginosa-induced mucus expression in human airways. Pulm Pharmacol Ther (2010) 0.79
Generation of an autologous cell system for immunotherapy of squamous cell carcinoma of the head and neck. Anticancer Res (2005) 0.79
Diagnosis and treatment of snoring in adults-S2k Guideline of the German Society of Otorhinolaryngology, Head and Neck Surgery. Sleep Breath (2014) 0.78
Human mesenchymal stromal cells from adipose tissue of the neck. Eur Arch Otorhinolaryngol (2012) 0.78
Plasmacytoid dendritic cell subpopulations in head and neck squamous cell carcinoma. Oncol Rep (2011) 0.78
Head and neck cancer triggers the internalization of TLR3 in natural killer cells. Int J Mol Med (2007) 0.78
Effect of steroids, acetyl-cysteine and calcium-activated chloride channel inhibitors on allergic mucin expression in sinus mucosa. Laryngoscope (2008) 0.78
A prospective evaluation of psychosocial outcomes following ear reconstruction with rib cartilage in microtia. J Plast Reconstr Aesthet Surg (2009) 0.78
Soluble CD44v6 is not a sensitive tumor marker in patients with head and neck squamous cell cancer. Anticancer Res (2005) 0.77
Effect of head and neck cancer supernatant and CpG-oligonucleotides on migration and IFN-alpha production of plasmacytoid dendritic cells. Anticancer Res (2009) 0.77
Decreased migration of myeloid dendritic cells through increased levels of C-reactive protein. Anticancer Res (2008) 0.77
Phase I/II clinical study on safety and antivascular effects of paclitaxel encapsulated in cationic liposomes for targeted therapy in advanced head and neck cancer. Head Neck (2013) 0.77
Biodistribution of 131I-labeled anti-CK8 monoclonal antibody in HNSCC in xenotransplanted SCID mice. Anticancer Res (2011) 0.77
The MEK1/2-ERK1/2 pathway is activated in chronic rhinosinusitis with nasal polyps. Arch Immunol Ther Exp (Warsz) (2014) 0.76
Limited suitability of EpCAM for molecular staging of tumor borders in head and neck cancer. Anticancer Res (2006) 0.76
Toll-like receptor interference in myeloid dendritic cells through head and neck cancer. Anticancer Res (2007) 0.76
The number of CD161 positive Th17 cells are decreased in head and neck cancer patients. Cell Immunol (2011) 0.76
Amplification options in unilateral aural atresia: an active middle ear implant or a bone conduction device? Otol Neurotol (2014) 0.76
Up-regulation of NK cell function against head and neck cancer in response to ss-isRNA requires TLR7. Int J Oncol (2008) 0.76
Cytokine release of human NK cells solely triggered with Poly I:C. Cell Immunol (2010) 0.76
Evaluation and development of a predictive model for ultrasound-guided investigation of neck metastases. Eur Arch Otorhinolaryngol (2011) 0.76
Diagnosis and treatment of snoring in adults--S1 guideline of the German Society of Otorhinolaryngology, Head and Neck Surgery. Sleep Breath (2010) 0.75
Expression of the T cell receptor αβ on a CD123+ BDCA2+ HLA-DR+ subpopulation in head and neck squamous cell carcinoma. PLoS One (2011) 0.75
Nuclear expression of p65 (RelA) in patients receiving post-operative radiotherapy for locally advanced squamous cell carcinoma of the head and neck. BMC Cancer (2015) 0.75
CpG-Induced IFN-α production of plasmacytoid dendritic cells: time and dosage dependence and the effect of structural modifications to the CpG backbone. Nucleic Acid Ther (2013) 0.75
Influence of silicone gel on standardized postoperative scars. J Dtsch Dermatol Ges (2013) 0.75
Prednisolone reduces TNF-alpha release by PBMCs activated with a trifunctional bispecific antibody but not their anti-tumor activity. Anticancer Res (2005) 0.75
Increased activation and differentiated localization of native and phosphorylated STAT3 in nasal polyps. Int Arch Allergy Immunol (2013) 0.75
Glycogen synthase kinase 3 in chronic rhinosinusitis: two faces of a single enzyme in one disease. Ann Allergy Asthma Immunol (2012) 0.75
Liposomal transfection of squamous carcinoma cells of the head and neck with IL-2 and B7 plasmids inducing an autologous immune response in vitro. Anticancer Res (2005) 0.75
Antitumour effects of a bispecific trivalent antibody in multicellular tumour spheroids. Anticancer Res (2004) 0.75
Evaluation of the prognostic role of tumor cell podoplanin expression in locally advanced squamous cell carcinoma of the head and neck. Strahlenther Onkol (2014) 0.75
Phase I clinical study of vascular targeting fluorescent cationic liposomes in head and neck cancer. Eur Arch Otorhinolaryngol (2012) 0.75
Borderline indications for ear reconstruction. Ann Plast Surg (2006) 0.75
The Vibrant Soundbridge in Children and Adolescents: Preliminary European Multicenter Results. Otol Neurotol (2015) 0.75
Laryngeal chondrosarcoma with unusual dissemination to the humerus. ORL J Otorhinolaryngol Relat Spec (2012) 0.75
Propofol in bronchoalveolar lavage during anaesthesia. Clin Chim Acta (2010) 0.75